Page last updated: 2024-08-23

raloxifene hydrochloride and d-alpha tocopherol

raloxifene hydrochloride has been researched along with d-alpha tocopherol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Lush, DT	1
Buchanan, CM; Caflisch, GB; Edgar, KJ; Large, SE; Lightner, JW; Little, JL; Rice, PJ; Ruble, KM; Wacher, VJ; Wempe, MF; Wright, C	1
Aurrekoetxea, I; del Agua, AR; Elorriaga, MA; Guéraud, F; Rodriguez, F; Ruiz-Larrea, MB; Ruiz-Sanz, JI	1
Ahmed, OAA; Alhakamy, NA; Fahmy, UA	1
Du, X; Gao, N; Song, X	1

Reviews

1 review(s) available for raloxifene hydrochloride and d-alpha tocopherol

Article	Year
Preventing heart disease and cancer. What randomized, primary-prevention studies show. Postgraduate medicine, 1999, Oct-15, Volume: 106, Issue:5 Topics: Aged; Antineoplastic Agents; Aspirin; Breast Neoplasms; Coronary Disease; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Primary Prevention; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selenium; Tamoxifen; Vitamin E	1999

Article

Year

Preventing heart disease and cancer. What randomized, primary-prevention studies show.

Postgraduate medicine, 1999, Oct-15, Volume: 106, Issue:5

Topics: Aged; Antineoplastic Agents; Aspirin; Breast Neoplasms; Coronary Disease; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Primary Prevention; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selenium; Tamoxifen; Vitamin E

1999

Other Studies

4 other study(ies) available for raloxifene hydrochloride and d-alpha tocopherol

Article	Year
Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS. International journal of pharmaceutics, 2009, Mar-31, Volume: 370, Issue:1-2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Carriers; Humans; Male; Mass Spectrometry; Polyethylene Glycols; Raloxifene Hydrochloride; Rats; Rats, Inbred Strains; Rhodamine 123; Surface-Active Agents; Vitamin E	2009
Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5 Topics: Acetylcysteine; alpha-Tocopherol; Antioxidants; Estradiol; Female; Hormone Replacement Therapy; Humans; Intercellular Adhesion Molecule-1; Lipids; Malondialdehyde; Middle Aged; Peroxidase; Polymorphism, Genetic; Postmenopause; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uric Acid	2011
Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene. PloS one, 2019, Volume: 14, Issue:12 Topics: Administration, Cutaneous; Animals; Anticarcinogenic Agents; Breast Neoplasms; Drug Carriers; Female; Humans; MCF-7 Cells; Raloxifene Hydrochloride; Rats, Wistar; Selective Estrogen Receptor Modulators; Skin Absorption; tat Gene Products, Human Immunodeficiency Virus; Vitamin E	2019
Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability. Drug delivery, 2021, Volume: 28, Issue:1 Topics: Acrylic Resins; Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Diglycerides; Drug Carriers; Humans; Liposomes; Nanoparticles; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Vitamin E	2021